Nabeel

32%
Flag icon
The doctors then used CRISPR-Cas9 to disable a gene that produces a protein, known as PD-1, which stops the cell’s immune response. Cancer cells sometimes trigger the PD-1 response, thus protecting themselves from the immune system.
The Code Breaker
Rate this book
Clear rating
Open Preview